At a glance
ClinicalIndex Comparison RecordN/ACompleted· 85 enrolled
Drug / intervention
Hepatic derived surgical matrixbiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Complications and 1-Year Outcomes Following Hiatal Hernia Repair With MIROMESH a Novel, Highly Vascular, Porcine Derived, Biologic Matrix
In Brief
An observational study evaluating Hepatic derived surgical matrix for Hiatal Hernia With Gastroesophageal Reflux Disease and 2 related conditions. Completed, enrolled 85 participants across 1 site.
Detailed Summary
Investigator will identify a consecutive cohort of patients who have undergone a hiatal hernia repair and are at least 6 months post index procedure.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartJun 2017
Primary CompletionJun 2018
Study CompletionOct 2018
First PostedNov 2018
TodayJul 2026
First PostedNov 8, 2018
Enrollment StartJun 1, 2017
Primary CompletionJun 1, 2018
Study CompletionOct 1, 2018
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 7.6 years ago
Interventions
Hepatic derived surgical matrixbiological
Hiatal hernia repair with MIROMESH